- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03584347
Evaluation of Physician Volumetric Accuracy During Filler Injections
January 8, 2019 updated by: Erevna Innovations Inc.
Evaluation of Physician Volumetric Accuracy During Hyaluronic Acid Soft Tissue Filler Injections and the Effect of Products' Biophysical Properties on an Injector's Performance: An Observational, Proof-of-concept Study
Objectives
- Evaluate the ability of aesthetic physicians to accurately inject a specific amount (i.e., 0.2cc) of HA soft tissue filler; and
- Investigate the effect of different HA gel properties (e.g., G', cohesivity, viscoelasticity) on an injector's performance accuracy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
13
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Westmount, Quebec, Canada, H3Z1C3
- Victoria Park Medispa
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Board-certified plastic surgeon, dermatologist, or oculoplastic surgeon.
Exclusion Criteria:
- N/A
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Volumetric accuracy of HA filler injections using observational methods
Time Frame: Baseline
|
physicians will attempt to inject 0.2CC of four HA products into a porcine membrane.
Volumes will be measured in CC's and their accuracy assessed based on the amount of product left in the syringe.
|
Baseline
|
|
Volumetric accuracy of HA filler expulsions over a scale
Time Frame: Baseline
|
Physicians will attempt to dispense 0.2CC of four different HA products.
They will do this into free air, over a scale.
The weights will be calculated in grams and converted to CC's.
The scale is the "Smart Weight" digital milligram scale, JDS20 edition.
It's specifications are as follows: capacity: 20g/100ct/308.8gn/12.86dwt;
readability: 0.001g/0.005ct/0.02gn/0.001dwt;
scale dimensions: 3x5x0.8";
accuracy of 0.001grams and capacity of 20grams.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 3, 2018
Primary Completion (Actual)
June 10, 2018
Study Completion (Actual)
September 3, 2018
Study Registration Dates
First Submitted
June 7, 2018
First Submitted That Met QC Criteria
June 28, 2018
First Posted (Actual)
July 12, 2018
Study Record Updates
Last Update Posted (Actual)
January 10, 2019
Last Update Submitted That Met QC Criteria
January 8, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 2018-06-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Injection Site
-
Jeffrey Alan Klein, MDNot yet recruitingAnesthesia, Local | Injection Site Irritation | Injection Site Discomfort | Injection Site Bruising | Benzoic Acid Adverse ReactionUnited States
-
Eastern Mediterranean UniversityCompletedInjection Site | Injection FearTurkey
-
Chang Gung Memorial HospitalRecruiting
-
Karadeniz Technical UniversityThe Scientific and Technological Research Council of TurkeyNot yet recruitingNursing Education | Injection Site | Cognitive OrientationTurkey
-
Assistance Publique - Hôpitaux de ParisCompletedInjection; Complications, Sepsis | Injection Site Disorder | Injection Site Extravasation | Intentional Poisoning by SiliconeFrance
-
Eitan MedicalThomas Jefferson UniversityRecruitingInjection Site Irritation | Injection Site Reaction | Injection SiteUnited States
-
Ankara City Hospital BilkentCompletedRegional Anesthesia Morbidity | Adult | Anesthesia Injection SiteTurkey
-
Ege UniversityUnknown
-
Ankara Diskapi Training and Research HospitalCompleted
-
Rabin Medical CenterUnknown
Clinical Trials on Injection of filler material
-
Al-Azhar UniversityCompleted
-
University of Southern CaliforniaSofregen Medical, Inc.CompletedDysphonia | Vocal Cord Paralysis Unilateral | Dysphagia, OropharyngealUnited States
-
DeNova ResearchGalderma R&DCompletedDeformity of Nasal CartilageUnited States
-
Samyang Biopharmaceuticals CorporationHangzhou Inshow Biotechnology Co.,Ltd.Not yet recruiting
-
Laboratoires FILLMEDCompleted
-
The Baruch Padeh Medical Center, PoriyaUnknownOsteoarthritis of Acromioclavicular Joint
-
Tissue GenesisU.S. Army Medical Research and Development CommandActive, not recruitingCritical Limb IschemiaUnited States
-
Maxigen Biotech Inc.Completed
-
SymateseActive, not recruiting
-
Northwestern UniversityCompleted